Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Moldenhauer

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
Protein Engineering|April 1, 1997
Two amino acid mutations in an anti-human CD3 single chain Fv antibody fragment that affect the yield on bacterial secretion but not the affinityS M Kipriyanov, G Moldenhauer, A C Martin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1986
Differential expression of Ia and Ia-associated invariant chain in mouse tissues after in vivo treatment with IFN-gammaF Momburg, N Koch, P Möller, et al.
Blood|August 1, 1988
B-cell proliferative and differentiative responses after autologous peripheral blood stem cell or bone marrow transplantationS Kiesel, A Pezzutto, G Moldenhauer, et al.
FEBS Letters|February 26, 1990
Monoclonal antibodies against the human lymphocyte differentiation antigen CD 76 bind to gangliosidesB Kniep, P F Mühlradt, B Dörken, et al.
International Journal of Cancer|July 15, 1994
Lymphotoxin-alpha/beta heterodimer is expressed on leukemic hairy cells and activated human B lymphocytesM Y Mapara, R C Bargou, C Beck, et al.
The British Journal of Cancer. Supplement|July 1, 1990
Antibody transport and internalization into tumoursS Matzku, G Moldenhauer, H Kalthoff, et al.
Blood|September 1, 1987
Monoclonal antibody Ki-B3 detects a formalin resistant antigen on normal and neoplastic B cellsA C Feller, H H Wacker, G Moldenhauer, et al.
The EMBO Journal|November 15, 1996
Editing of the HLA-DR-peptide repertoire by HLA-DMH Kropshofer, A B Vogt, G Moldenhauer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1987
CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferationA Pezzutto, B Dörken, P S Rabinovitch, et al.
Blood|December 9, 1998
Immunotherapy of B-cell lymphoma with CD3x19 bispecific antibodies: costimulation via CD28 prevents "veto" apoptosis of antibody-targeted cytotoxic T cellsP T Daniel, A Kroidl, J Kopp, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Protein Engineering|April 1, 1997
Two amino acid mutations in an anti-human CD3 single chain Fv antibody fragment that affect the yield on bacterial secretion but not the affinityS M Kipriyanov, G Moldenhauer, A C Martin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1986
Differential expression of Ia and Ia-associated invariant chain in mouse tissues after in vivo treatment with IFN-gammaF Momburg, N Koch, P Möller, et al.
Blood|August 1, 1988
B-cell proliferative and differentiative responses after autologous peripheral blood stem cell or bone marrow transplantationS Kiesel, A Pezzutto, G Moldenhauer, et al.
FEBS Letters|February 26, 1990
Monoclonal antibodies against the human lymphocyte differentiation antigen CD 76 bind to gangliosidesB Kniep, P F Mühlradt, B Dörken, et al.
International Journal of Cancer|July 15, 1994
Lymphotoxin-alpha/beta heterodimer is expressed on leukemic hairy cells and activated human B lymphocytesM Y Mapara, R C Bargou, C Beck, et al.
The British Journal of Cancer. Supplement|July 1, 1990
Antibody transport and internalization into tumoursS Matzku, G Moldenhauer, H Kalthoff, et al.
Blood|September 1, 1987
Monoclonal antibody Ki-B3 detects a formalin resistant antigen on normal and neoplastic B cellsA C Feller, H H Wacker, G Moldenhauer, et al.
The EMBO Journal|November 15, 1996
Editing of the HLA-DR-peptide repertoire by HLA-DMH Kropshofer, A B Vogt, G Moldenhauer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1987
CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferationA Pezzutto, B Dörken, P S Rabinovitch, et al.
Blood|December 9, 1998
Immunotherapy of B-cell lymphoma with CD3x19 bispecific antibodies: costimulation via CD28 prevents "veto" apoptosis of antibody-targeted cytotoxic T cellsP T Daniel, A Kroidl, J Kopp, et al.
Pageof 13